ZA969564B - Synergistic herbicidal mixtures - Google Patents

Synergistic herbicidal mixtures

Info

Publication number
ZA969564B
ZA969564B ZA969564A ZA969564A ZA969564B ZA 969564 B ZA969564 B ZA 969564B ZA 969564 A ZA969564 A ZA 969564A ZA 969564 A ZA969564 A ZA 969564A ZA 969564 B ZA969564 B ZA 969564B
Authority
ZA
South Africa
Prior art keywords
synergistic herbicidal
herbicidal mixtures
mixtures
synergistic
herbicidal
Prior art date
Application number
ZA969564A
Other languages
English (en)
Inventor
Richard Rees
Juergen Bohner
Eberhard Richter
Original Assignee
Hoechst Schering Agrevo Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Schering Agrevo Gmbh filed Critical Hoechst Schering Agrevo Gmbh
Publication of ZA969564B publication Critical patent/ZA969564B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
ZA969564A 1995-11-15 1996-11-14 Synergistic herbicidal mixtures ZA969564B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19544393A DE19544393A1 (de) 1995-11-15 1995-11-15 Synergistische herbizide Mischungen

Publications (1)

Publication Number Publication Date
ZA969564B true ZA969564B (en) 1997-05-15

Family

ID=7778639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969564A ZA969564B (en) 1995-11-15 1996-11-14 Synergistic herbicidal mixtures

Country Status (18)

Country Link
US (1) US6013605A (fr)
EP (1) EP0863705B1 (fr)
JP (1) JP3920341B2 (fr)
KR (1) KR100427960B1 (fr)
CN (1) CN1084148C (fr)
AU (1) AU711841B2 (fr)
BR (1) BR9611478A (fr)
CA (1) CA2236592C (fr)
DE (2) DE19544393A1 (fr)
ES (1) ES2178720T3 (fr)
MX (1) MX9803824A (fr)
MY (1) MY114731A (fr)
RU (1) RU2170017C2 (fr)
TR (1) TR199800794T2 (fr)
TW (1) TW355125B (fr)
UA (1) UA48203C2 (fr)
WO (1) WO1997017852A1 (fr)
ZA (1) ZA969564B (fr)

Families Citing this family (240)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836684A1 (de) 1998-08-13 2000-02-17 Hoechst Schering Agrevo Gmbh Herbizide Mittel für tolerante oder resistente Reiskulturen
KR100338621B1 (ko) * 2000-01-24 2002-05-30 전광술 제초제 및 그 제조방법
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
AU2002318371B2 (en) 2001-06-20 2006-06-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2003017764A1 (fr) 2001-08-23 2003-03-06 Bayer Cropscience S.A. Amines propargyliques substituees
DE60238143D1 (de) 2001-09-18 2010-12-09 Genentech Inc Zusammensetzungen und verfahren für die diagnose von tumoren
WO2003057160A2 (fr) 2002-01-02 2003-07-17 Genentech, Inc. Compositions et methodes de diagnostic et de traitement d'une tumeur
KR100429139B1 (ko) * 2002-02-28 2004-04-29 한국화학연구원 싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법
CA2481507A1 (fr) 2002-04-16 2003-10-30 Genentech, Inc. Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
EP2305710A3 (fr) 2002-06-03 2013-05-29 Genentech, Inc. Bibliothèques de phages et anticorps synthétiques
PT1610820E (pt) 2003-04-04 2010-12-16 Novartis Ag Formulações de elevada concentração de anticorpos e proteínas
US6849579B2 (en) * 2003-06-25 2005-02-01 Pbi Gordon Corporation Synergistic quinclorac herbicidal compositions
DK1641822T3 (da) 2003-07-08 2013-07-22 Genentech Inc Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
ES2472690T3 (es) 2003-11-17 2014-07-02 Genentech, Inc. Anticuerpo contra CD22 para el tratamiento de tumores de origen hematopoy�tico
JP4570890B2 (ja) * 2004-03-26 2010-10-27 協友アグリ株式会社 除草剤組成物
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
KR20200058588A (ko) 2005-01-21 2020-05-27 제넨테크, 인크. Her 항체의 고정 용량 투여법
ZA200707078B (en) 2005-02-23 2008-11-26 Genentech Inc Extending time to disease progression or survival in cancer patients
EP1853288A2 (fr) 2005-02-23 2007-11-14 Alza Corporation, Inc. Administration intranasale d'agents actifs dans le systeme nerveux central
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
WO2006094269A2 (fr) 2005-03-03 2006-09-08 Covx Technologies Ireland Limited Composes antiangiogeniques
NZ563341A (en) 2005-06-06 2009-10-30 Genentech Inc Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
EP1922410A2 (fr) 2005-08-15 2008-05-21 Genentech, Inc. Disruptions et compositions géniques et procédés associés
CA2630432A1 (fr) 2005-11-21 2007-07-19 Genentech, Inc. Nouvelles dissociations de genes, compositions et procedes les concernant
US20080311107A1 (en) 2006-02-17 2008-12-18 Genetech, Inc. Novel Gene Disruptions, Compositions and Methods Relating Thereto
UA100969C2 (uk) 2006-03-21 2013-02-25 Дженентек, Інк. Антитіло, яке специфічно зв'язує людський альфа5бета1 (alpha5beta1)
AU2007243946B2 (en) 2006-04-05 2012-11-29 Curis, Inc. Method for using BOC/CDO to modulate hedgehog signaling
AU2007297565A1 (en) 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
CL2007001623A1 (es) 2006-06-06 2008-01-18 Genentech Inc Anticuerpo anti-dll4; polinucleotido que lo codifica; vector y celula huesped que comprenden dicho polinucleotido; metodo para elaborar el anticuerpo e inmunojugado; metodo de deteccion de dll4 y metodo diagnostico de un trastorno asociado a dll4; composicion que comprende al anticuerpo.
US8874380B2 (en) 2010-12-09 2014-10-28 Rutgers, The State University Of New Jersey Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
CA2660286A1 (fr) 2006-08-09 2008-02-21 Homestead Clinical Corporation Proteines specifiques d'organes et procedes d'utilisation
US10118970B2 (en) 2006-08-30 2018-11-06 Genentech, Inc. Multispecific antibodies
MY146985A (en) 2006-11-10 2012-10-15 Covx Technologies Ireland Ltd Anti-angiogenic compounds
AU2008218199B2 (en) 2007-02-22 2013-10-31 Genentech, Inc. Methods for detecting inflammatory bowel disease
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
ES2583377T3 (es) 2007-06-08 2016-09-20 Genentech, Inc. Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
CN101802013B (zh) 2007-07-16 2014-07-02 健泰科生物技术公司 人源化抗cd79b抗体和免疫偶联物及使用方法
PE20090943A1 (es) 2007-07-16 2009-08-05 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados
AU2008323701B2 (en) 2007-11-07 2015-03-26 Genentech, Inc Methods and compositions for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
CN104059143A (zh) 2007-11-12 2014-09-24 特罗科隆科学有限公司 用于对流行性感冒进行治疗以及诊断的组合物以及方法
EP2657253B1 (fr) 2008-01-31 2017-07-19 Genentech, Inc. Anticorps anti-CD79b et immuno-conjugués et procédés d'utilisation
MX2010009885A (es) 2008-03-10 2010-11-30 Theraclone Sciences Inc Composiciones y métodos para la terapia y diagnóstico de citomegalovirus.
AU2009231733B2 (en) 2008-03-31 2015-12-24 Genentech, Inc. Compositions and methods for treating and diagnosing asthma
US20100255508A1 (en) 2008-05-16 2010-10-07 Thomas Richard Gelzleichter Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
PL2307459T3 (pl) 2008-07-08 2015-05-29 Oncomed Pharm Inc Czynniki wiążące receptor Notch1 i sposoby ich stosowania
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
CN101352171B (zh) * 2008-09-19 2012-07-04 北京燕化永乐农药有限公司 吡嘧磺隆与甲羧除草醚农药的除草剂组合物
ES2766257T3 (es) 2008-11-13 2020-06-12 Massachusetts Gen Hospital Métodos y composiciones para regular la homeostasis del hierro mediante la modulación de bmp-6
US8211434B2 (en) 2008-11-26 2012-07-03 Allergan, Inc. KLK-13 antibody inhibitor for treating dry eye
CN114835812A (zh) 2008-12-09 2022-08-02 霍夫曼-拉罗奇有限公司 抗-pd-l1抗体及它们用于增强t细胞功能的用途
SI3260136T1 (sl) 2009-03-17 2021-05-31 Theraclone Sciences, Inc. Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
RU2504553C2 (ru) 2009-03-20 2014-01-20 Дженентек, Инк. Антитела к her
MA33248B1 (fr) 2009-04-01 2012-05-02 Genentech Inc Traitement de troubles résistant à l'insuline
WO2010120561A1 (fr) 2009-04-01 2010-10-21 Genentech, Inc. Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
US20100297127A1 (en) 2009-04-08 2010-11-25 Ghilardi Nico P Use of il-27 antagonists to treat lupus
EP2419531B1 (fr) 2009-04-18 2016-09-07 Genentech, Inc. Méthodes d'évaluation de la réactivité du lymphome b à un traitement utilisant un anticorps anti-cd40
SG175305A1 (en) 2009-04-23 2011-11-28 Theraclone Sciences Inc Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
CA2762302A1 (fr) 2009-05-20 2010-11-25 Theraclone Sciences, Inc. Compositions et procedes pour le traitement et le diagnostic de la grippe
US20110038871A1 (en) 2009-08-11 2011-02-17 Veena Viswanth Ccr2 inhibitors for treating conditions of the eye
JP5819308B2 (ja) 2009-10-22 2015-11-24 ジェネンテック, インコーポレイテッド マクロファージ刺激タンパク質のヘプシン活性化を調節するための方法及び組成物
WO2011056494A1 (fr) 2009-10-26 2011-05-12 Genentech, Inc. Combinaisons d'antagonistes de la kinase-1 du type récepteur de l'activine et d'antagonistes vegfr3
WO2011056497A1 (fr) 2009-10-26 2011-05-12 Genentech, Inc. Compositions de récepteur de l'activine de type iib et leurs méthodes d'utilisation
KR101832510B1 (ko) 2009-10-26 2018-02-26 제넨테크, 인크. 치료 항-ige 항체에 대해 특이적인 항체를 검출하기 위한 검정 및 아나필락시스에서의 이의 용도
WO2011056502A1 (fr) 2009-10-26 2011-05-12 Genentech, Inc. Compositions du gene recepteur de proteine morphogenetique osseuse type ii et procedes d'utilisation
CA2781887C (fr) 2009-11-30 2018-03-27 Genentech, Inc. Compositions et procedes destines a diagnostiquer et a traiter des tumeurs
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US20110159588A1 (en) 2009-12-30 2011-06-30 Kui Lin Methods for Modulating a PDGF-AA Mediated Biological Response
AR080243A1 (es) 2010-02-23 2012-03-21 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores
WO2011130332A1 (fr) 2010-04-12 2011-10-20 Academia Sinica Puces au glycane pour la recherche par criblage haut débit de virus
WO2011133931A1 (fr) 2010-04-22 2011-10-27 Genentech, Inc. Utilisation d'antagonistes d'il-27 pour traiter une maladie intestinale inflammatoire
CN102958538A (zh) 2010-05-03 2013-03-06 弗·哈夫曼-拉罗切有限公司 用于降低含有蛋白质的制剂的粘度的组合物和方法
CA2835489C (fr) 2010-05-10 2018-03-06 Chi-Huey Wong Congeneres de phosphonate de zanamivir ayant une activite antigrippale et determination de la sensibilite a l'oseltamivir d'influenzavirus
CN102265853A (zh) * 2010-06-04 2011-12-07 南京华洲药业有限公司 一种含灭草松和二氯喹啉酸的除草组合物及其应用
US20110311527A1 (en) 2010-06-16 2011-12-22 Allergan, Inc. IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
US8900590B2 (en) 2010-08-12 2014-12-02 Theraclone Sciences, Inc. Anti-hemagglutinin antibody compositions and methods of use thereof
EP2420250A1 (fr) 2010-08-13 2012-02-22 Universitätsklinikum Münster Anticorps anti-syndecan-4
JP2013537416A (ja) 2010-08-13 2013-10-03 メディミューン リミテッド 変異型Fc領域を含むモノマーポリペプチド及び使用方法
WO2012022734A2 (fr) 2010-08-16 2012-02-23 Medimmune Limited Anticorps anti-icam-1 et procédés d'utilisation
SI3556396T1 (sl) 2010-08-31 2022-09-30 Theraclone Sciences, Inc. Nevtralizacijska protitelesa proti virusu človeške imunske pomanjkljivosti (HIV)
WO2012092539A2 (fr) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Anticorps contre dll4 et leurs utilisations
TW201245223A (en) 2011-02-14 2012-11-16 Theraclone Sciences Inc Compositions and methods for the therapy and diagnosis of influenza
KR20140012131A (ko) 2011-03-15 2014-01-29 테라클론 사이언시스, 아이엔씨. 인플루엔자의 치료 및 진단을 위한 조성물 및 방법
CN114642731A (zh) 2011-03-31 2022-06-21 豪夫迈·罗氏有限公司 施用β7整联蛋白拮抗剂的方法
JP6196613B2 (ja) 2011-05-08 2017-09-13 レゴケム バイオサイエンシズ, インク.Legochem Biosciences, Inc. タンパク質−活性剤コンジュゲートおよびこれを調製するための方法
MX358099B (es) 2011-05-17 2018-08-06 Univ Rockefeller Anticuerpos que neutralizan el virus de inmunodeficiencia humano y metodos de uso de ellos.
CA2836373A1 (fr) 2011-06-06 2012-12-13 Neotope Biosciences Limited Antagonistes de mcam et methodes de traitement
JP2013040160A (ja) 2011-07-01 2013-02-28 Genentech Inc 自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
WO2013015821A1 (fr) 2011-07-22 2013-01-31 The Research Foundation Of State University Of New York Anticorps anti-récepteur de b12-transcobalamine
US9890207B2 (en) 2011-07-25 2018-02-13 California Institute Of Technology Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
US9493549B2 (en) 2011-07-25 2016-11-15 The Rockefeller University Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
US8822651B2 (en) 2011-08-30 2014-09-02 Theraclone Sciences, Inc. Human rhinovirus (HRV) antibodies
EP3663314A1 (fr) 2012-01-09 2020-06-10 The Scripps Research Institute Anticorps humanisés avec cdr3s ultralong
EP2802603A4 (fr) 2012-01-09 2015-11-04 Scripps Research Inst Régions déterminant la complémentarité ultralongues et utilisations associées
BR112014018471A2 (pt) 2012-01-31 2017-07-04 Genentech Inc anticorpos anti-ige m1' e métodos para o seu uso
US20130259867A1 (en) 2012-03-27 2013-10-03 Genentech, Inc. Diagnosis and treatments relating to her3 inhibitors
WO2013148232A1 (fr) 2012-03-27 2013-10-03 Genentech, Inc. Procédés applicables au pronostic, au diagnostic, et au traitement de la fibrose pulmonaire idiopathique
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013192589A1 (fr) 2012-06-21 2013-12-27 California Institute Of Technology Anticorps ciblant des mutants échappés du vih
WO2014018375A1 (fr) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 et ses utilisations dans des méthodes thérapeutiques et diagnostiques
CA2880701A1 (fr) 2012-08-18 2014-02-27 Academia Sinica Sondes permeables aux cellules pour l'identification et l'imagerie de sialidases
AU2013305827A1 (en) 2012-08-21 2015-03-05 Academia Sinica Benzocyclooctyne compounds and uses thereof
TWI660972B (zh) 2012-09-10 2019-06-01 愛爾蘭商尼歐托普生物科學公司 抗mcam抗體及相關使用方法
CN104870056A (zh) 2012-10-05 2015-08-26 弗·哈夫曼-拉罗切有限公司 用于诊断和治疗炎性肠病的方法
EP2908912B1 (fr) 2012-10-18 2020-08-05 The Rockefeller University Anticorps anti-vih à neutralisation large
WO2014063205A1 (fr) 2012-10-26 2014-05-01 The University Of Queensland Utilisation d'inhibiteurs de l'endocytose et d'anticorps pour une thérapie anticancéreuse
SG11201507974RA (en) 2013-03-27 2015-10-29 Genentech Inc Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
EP2983710B1 (fr) 2013-04-09 2019-07-31 Annexon, Inc. Méthodes de traitement d'une neuromyélite optique
WO2014210397A1 (fr) 2013-06-26 2014-12-31 Academia Sinica Antigènes rm2 et leur utilisation
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
BR112016000106B1 (pt) 2013-07-09 2023-11-21 Annexon, Inc. Anticorpos anti-c1q e usos dos mesmos, célula de hibridoma, composição farmacêutica e métodos de detecção de sinapses em uma amostra biológica referências cruzadas a pedidos relacionados
AU2014290361B2 (en) 2013-07-18 2019-04-18 Taurus Biosciences, Llc Humanized antibodies with ultralong complementarity determining regions
EP3022224A2 (fr) 2013-07-18 2016-05-25 Fabrus, Inc. Anticorps à régions de détermination de complémentarité ultralongues
WO2015035337A1 (fr) 2013-09-06 2015-03-12 Academia Sinica Activation des cellules humaines inkt à l'aide de glycolipides ayant des groupes glycolsyles modifiés
WO2015050959A1 (fr) 2013-10-01 2015-04-09 Yale University Anticorps anti-kits et leurs méthodes d'utilisation
CA3204788A1 (fr) 2013-12-20 2015-06-25 Genentech, Inc. Anticorps comprenant un site de liaison d'antigenes se liant precisementa deux determinants antigeniques differents, et methodes de production
AU2015206788B2 (en) 2014-01-14 2019-10-24 The Medical College Of Wisconsin, Inc. Targeting CLPTM1L for treatment and prevention of cancer
CA2937123A1 (fr) 2014-01-16 2015-07-23 Academia Sinica Compositions et methodes pour traiter et detecter des cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015116902A1 (fr) 2014-01-31 2015-08-06 Genentech, Inc. Récepteurs couplés aux protéines g dans la signalisation hedgehog
SG11201607938UA (en) 2014-03-27 2016-10-28 Genentech Inc Methods for diagnosing and treating inflammatory bowel disease
WO2015148915A1 (fr) 2014-03-27 2015-10-01 Academia Sinica Composés de marquage réactifs et leurs utilisations
CN104012547A (zh) * 2014-05-07 2014-09-03 广东中迅农科股份有限公司 一种含有双唑草腈和氰氟草酯的除草组合物
CN104012549B (zh) * 2014-05-07 2016-08-17 广东中迅农科股份有限公司 一种含有双唑草腈和双草醚的除草组合物
JP6832709B2 (ja) 2014-05-16 2021-02-24 メディミューン,エルエルシー 新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
TWI717319B (zh) 2014-05-27 2021-02-01 中央研究院 得自類桿菌屬之岩藻糖苷酶及其用途
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CN106661099A (zh) 2014-05-27 2017-05-10 中央研究院 抗her2醣抗体及其用途
CN106573971A (zh) 2014-05-27 2017-04-19 中央研究院 抗cd20醣抗体及其用途
AU2015267044A1 (en) 2014-05-28 2016-12-15 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
US10584171B2 (en) 2014-05-30 2020-03-10 Henlix Biotech Co., Ltd. Anti-epidermal growth factor receptor (EGFR) antibodies
SG11201700901SA (en) 2014-08-08 2017-03-30 Alector Llc Anti-trem2 antibodies and methods of use thereof
US9879042B2 (en) 2014-09-08 2018-01-30 Academia Sinica Human iNKT cell activation using glycolipids
CN104255750A (zh) * 2014-09-10 2015-01-07 广东中迅农科股份有限公司 含有双唑草腈和丙草胺的除草组合物
WO2016073157A1 (fr) 2014-11-06 2016-05-12 Genentech, Inc. Anticorps anti-ang2 et procédés d'utilisation de ces anticorps
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
CN107427004B (zh) 2015-01-22 2021-06-08 巴斯夫农业公司 包含苯嘧磺草胺的三元除草组合
EP3789766A1 (fr) 2015-01-24 2021-03-10 Academia Sinica Nouveaux conjugués de glycane et leurs procédés d'utilisation
WO2016123329A2 (fr) 2015-01-28 2016-08-04 Genentech, Inc. Marqueurs d'expression génique et traitement de la sclérose en plaques
EP3978530A1 (fr) 2015-02-26 2022-04-06 F. Hoffmann-La Roche AG Antagonistes d'intégrine bêta7 et procédés de traitement de la maladie de crohn
JP6903587B2 (ja) 2015-04-03 2021-07-14 ユーリカ セラピューティックス, インコーポレイテッド Afpペプチド/mhc複合体を標的化する構築物およびその使用
SG10201912087SA (en) 2015-04-07 2020-02-27 Alector Llc Anti-sortilin antibodies and methods of use thereof
CN104757013A (zh) * 2015-04-18 2015-07-08 广东中迅农科股份有限公司 含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物
WO2016191811A1 (fr) 2015-06-03 2016-12-08 The University Of Queensland Agents mobilisateurs et leurs utilisations
SG10201912085WA (en) 2015-06-12 2020-02-27 Alector Llc Anti-cd33 antibodies and methods of use thereof
JP2018518491A (ja) 2015-06-12 2018-07-12 アレクトル エルエルシー 抗cd33抗体及びその使用方法
KR102549057B1 (ko) 2015-07-10 2023-06-29 바스프 아그로 비.브이. 신메틸린 및 아세토클로르 또는 프레틸라클로르를 포함하는 제초제 조성물
PL3319427T3 (pl) 2015-07-10 2020-05-18 BASF Agro B.V. Kompozycja chwastobójcza zawierająca cynmetalinę i dimetenamid
PL3319434T3 (pl) 2015-07-10 2019-11-29 Basf Agro Bv Kompozycja chwastobójcza zawierająca cynmetylinę i petoksamid
CN107846891B (zh) 2015-07-10 2024-02-20 巴斯夫农业公司 包含环庚草醚和特异性色素合成抑制剂的除草组合物
US11219212B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and imazamox
US11219215B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
WO2017009144A1 (fr) * 2015-07-10 2017-01-19 BASF Agro B.V. Composition herbicide à base de cinméthyline et d'acides quinoléine-carboxyliques spécifiques
CN107846889B (zh) 2015-07-10 2020-12-08 巴斯夫农业公司 包含环庚草醚和派罗克杀草砜的除草组合物
BR112018000482B1 (pt) 2015-07-10 2022-11-22 BASF Agro B.V. Composição herbicida, uso da composição e método para o controle da vegetação indesejada
CN105076162B (zh) * 2015-08-05 2018-03-09 安徽华星化工有限公司 一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物
US10590198B2 (en) 2015-08-28 2020-03-17 Alector Llc Anti-siglec-7 antibodies and methods of use thereof
CN108738323B (zh) 2015-10-06 2023-05-26 艾利妥 抗trem2抗体及其使用方法
CN115927191A (zh) 2015-10-23 2023-04-07 优瑞科生物技术公司 抗体/t细胞受体嵌合构建体及其用途
CN108431041B (zh) 2015-10-29 2022-08-16 艾利妥 抗siglec-9抗体及其使用方法
EP3380124B1 (fr) 2015-11-25 2024-04-03 LegoChem Biosciences, Inc. Conjugués comprenant des groupes auto-immolables et procédés associés
EP3397287A1 (fr) 2015-12-30 2018-11-07 Genentech, Inc. Formulations présentant une moindre dégradation des polysorbates
JP7023853B2 (ja) 2016-03-04 2022-02-22 アレクトル エルエルシー 抗trem1抗体及びその使用方法
EP3426693A4 (fr) 2016-03-08 2019-11-13 Academia Sinica Procédés de synthèse modulaire de n-glycanes et de puces à n-glycanes
CN105901005A (zh) * 2016-05-16 2016-08-31 河北博嘉农业有限公司 一种含有双唑草腈的除草组合物
CN105918339A (zh) * 2016-05-19 2016-09-07 河北博嘉农业有限公司 一种含有双唑草腈和磺酰脲类除草剂的除草组合物
WO2018014260A1 (fr) 2016-07-20 2018-01-25 Nanjing Legend Biotech Co., Ltd. Protéines de liaison antigènes multi-spécifiques et leurs procédés d'utilisation
CA3034057A1 (fr) 2016-08-22 2018-03-01 CHO Pharma Inc. Anticorps, fragments de liaison, et procedes d'utilisation
CN109923126B (zh) 2016-09-16 2022-06-03 上海复宏汉霖生物技术股份有限公司 抗-pd-1抗体
WO2018068201A1 (fr) 2016-10-11 2018-04-19 Nanjing Legend Biotech Co., Ltd. Anticorps à domaine unique et ses variants contre ctla-4
CN108064865A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064866A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064871A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064860A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064868A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN106561695A (zh) * 2016-11-15 2017-04-19 江苏龙灯化学有限公司 一种除草组合物
KR102085798B1 (ko) 2016-12-28 2020-03-06 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
EP3568468A4 (fr) 2017-01-12 2020-12-30 Eureka Therapeutics, Inc. Produits de recombinaison ciblant les complexes peptide histone h3/mhc, et leurs utilisations
WO2018152496A1 (fr) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Compositions et méthodes de diagnostic et de traitement de l'infection par le virus zika
CN106857579A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与三嗪氟草胺的除草组合物及其应用
CN107047594A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用
CN106857609A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用
CN107047582A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与禾草畏的除草组合物及其应用
CN106889083B (zh) * 2017-02-27 2019-02-12 南京华洲药业有限公司 一种含双唑草腈与异恶草酮的除草组合物及其应用
CN106857578A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙草胺的除草组合物及其应用
CN106857577A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与氟硫草定的除草组合物及其应用
CN107047593A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与乙氧磺隆的除草组合物及其应用
CN106857621A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与禾草敌的除草组合物及其应用
CN107047578A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与丙炔噁草酮的除草组合物及其应用
CN106889084A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与灭草松的除草组合物及其应用
CN107047592A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与苄嘧磺隆的除草组合物及其应用
CN106857580A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与吡氟酰草胺的除草组合物及其应用
CN106857600A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与异丙隆的除草组合物及其应用
CN106889082A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与噁草酮的除草组合物及其应用
CN106857576A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与苯噻酰草胺的除草组合物及其应用
CN106889094A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与吡嘧磺隆的除草组合物及其应用
CN106857575A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与丁草胺的除草组合物及其应用
RU2665790C1 (ru) 2017-04-17 2018-09-04 Закрытое Акционерное Общество "Биокад" Моноклональное антитело к pd-l1
WO2018200742A1 (fr) 2017-04-25 2018-11-01 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Anticorps et procédés de diagnostic et de traitement d'infection par le virus d'epstein barr
CA3059820A1 (fr) 2017-04-26 2018-11-01 Eureka Therapeutics, Inc. Constructions reconnaissant specifiquement le glypicane 3 et utilisations de ces dernieres
US11965021B2 (en) 2017-04-26 2024-04-23 Eureka Therapeutics, Inc. Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof
EP3625258A1 (fr) 2017-05-16 2020-03-25 Alector LLC Anticorps anti-siglec-5 et leurs procédés d'utilisation
CN107114382A (zh) * 2017-05-22 2017-09-01 娄天成 一种含双唑草腈和敌稗的农药组合物及其应用
CN107094781A (zh) * 2017-05-22 2017-08-29 孙金金 一种含双唑草腈和二氯喹啉酸的农药组合物及其应用
CN106954634A (zh) * 2017-05-22 2017-07-18 娄天成 一种含双唑草腈和莎稗磷的农药组合物及其应用
EP3630830A1 (fr) 2017-05-23 2020-04-08 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Nouvel anticorps anti-cd73 et utilisations associées
CN107006498A (zh) * 2017-05-24 2017-08-04 江苏省农用激素工程技术研究中心有限公司 用于防除稻田杂草的除草组合物
RU2653545C1 (ru) * 2017-07-17 2018-05-11 АО "Щелково Агрохим" Гербицидная композиция на основе бентазона для защиты зернобобовых культур
EP3655430A1 (fr) 2017-07-19 2020-05-27 The U.S.A. as represented by the Secretary, Department of Health and Human Services Anticorps et procédés de diagnostic et de traitement d'infection par le virus de l'hépatite b
BR112019023789A2 (pt) 2017-08-03 2020-07-28 Alector Llc anticorpos anti-cd33 e métodos de uso dos mesmos
WO2019028292A1 (fr) 2017-08-03 2019-02-07 Alector Llc Anticorps anti-trem2 et leurs procédés d'utilisation
RU2698048C2 (ru) 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
EA039662B1 (ru) 2017-10-03 2022-02-24 Закрытое Акционерное Общество "Биокад" Антитела, специфичные к cd47 и pd-l1
CA3085472A1 (fr) 2017-12-19 2019-06-27 The Rockefeller University Variants de domaine fc de l'igg humaine a fonction d'effecteur amelioree
TW201930358A (zh) 2017-12-28 2019-08-01 大陸商南京傳奇生物科技有限公司 針對tigit之單域抗體及其變異體
KR20200120641A (ko) 2018-01-15 2020-10-21 난징 레전드 바이오테크 씨오., 엘티디. Pd-1에 대한 단일-도메인 항체 및 이의 변이체
CN111954541A (zh) 2018-01-25 2020-11-17 Acm生物实验室私人有限公司 包含可溶性包封抗原的聚合物囊泡以及其制备方法和用途
CN108371183A (zh) * 2018-02-02 2018-08-07 河北中天邦正生物科技股份公司 一种农药组合物及其应用
CN108308187A (zh) * 2018-02-11 2018-07-24 河北中天邦正生物科技股份公司 一种农药组合物及其应用
US11958903B2 (en) 2018-03-30 2024-04-16 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies against LAG-3 and uses thereof
EP3788071A1 (fr) 2018-05-02 2021-03-10 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Anticorps et méthodes de diagnostic, de prévention et de traitement d'infection par le virus d'epstein barr
LT3618928T (lt) 2018-07-13 2023-04-11 Alector Llc Anti-sortilino antikūnai ir jų panaudojimo būdai
EA202190183A1 (ru) 2018-07-27 2021-05-18 Алектор Ллс Антитела к siglec-5 и способы их применения
WO2020053325A1 (fr) 2018-09-12 2020-03-19 Acm Biolabs Pte Ltd Polymersomes comprenant un antigène lié de manière covalente ainsi que leurs procédés de préparation et utilisations associées
RU2724469C2 (ru) 2018-10-31 2020-06-23 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с cd20
EP3880714A4 (fr) 2018-11-16 2022-07-20 Memorial Sloan Kettering Cancer Center Anticorps dirigés contre la mucine-16 et leurs procédés d'utilisation
RU2734432C1 (ru) 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
JP2022530482A (ja) 2019-05-02 2022-06-29 レゴケム バイオサイエンシズ, インク. トリス構造を有するリンカーを含むリガンド―薬物複合体
AR119293A1 (es) 2019-06-28 2021-12-09 Genentech Inc Composición y métodos para estabilizar formulaciones líquidas de proteínas
CN110178842A (zh) * 2019-07-05 2019-08-30 南京农业大学 一种丙草胺与双唑草腈治理抗性稗组合物及其应用
JP2022540806A (ja) 2019-07-19 2022-09-20 オンコレスポンス,インク. 免疫調節抗体およびその使用方法
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
CN113993900B (zh) 2020-05-27 2023-08-04 舒泰神(北京)生物制药股份有限公司 特异性识别神经生长因子的抗体及其用途
MX2023008485A (es) 2021-01-20 2023-07-28 Oncoresponse Inc Anticuerpos inmunomoduladores y usos de estos.
AU2022258552A1 (en) 2021-04-12 2023-10-19 Acm Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
WO2023283611A1 (fr) 2021-07-08 2023-01-12 Staidson Biopharma Inc. Anticorps reconnaissant spécifiquement le tnfr2 et leurs utilisations
CN115812082A (zh) 2021-07-14 2023-03-17 舒泰神(北京)生物制药股份有限公司 特异性识别cd40的抗体及其应用
WO2024020407A1 (fr) 2022-07-19 2024-01-25 Staidson Biopharma Inc. Anticorps reconnaissant spécifiquement l'atténuateur de lymphocytes b et t (btla) et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL116507A (en) * 1991-11-13 1997-08-14 Schering Ag Pyrazole derivatives
DK0663913T3 (da) * 1992-10-12 1999-05-03 Hoechst Schering Agrevo Gmbh Nye substituerede pyrazolderivater, fremgangsmåder til deres fremstilling samt deres anvendelse som herbicider

Also Published As

Publication number Publication date
UA48203C2 (uk) 2002-08-15
WO1997017852A1 (fr) 1997-05-22
US6013605A (en) 2000-01-11
DE19544393A1 (de) 1997-05-22
EP0863705B1 (fr) 2002-06-12
ES2178720T3 (es) 2003-01-01
CA2236592A1 (fr) 1997-05-22
DE59609348D1 (de) 2002-07-18
AU711841B2 (en) 1999-10-21
KR100427960B1 (ko) 2005-01-15
TR199800794T2 (xx) 1998-08-21
EP0863705A1 (fr) 1998-09-16
CA2236592C (fr) 2005-01-04
BR9611478A (pt) 1999-07-13
RU2170017C2 (ru) 2001-07-10
TW355125B (en) 1999-04-01
JP2000500445A (ja) 2000-01-18
MY114731A (en) 2002-12-31
CN1084148C (zh) 2002-05-08
MX9803824A (es) 1998-09-30
JP3920341B2 (ja) 2007-05-30
AU7569696A (en) 1997-06-05
CN1201370A (zh) 1998-12-09
KR19990067314A (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
ZA969564B (en) Synergistic herbicidal mixtures
HUP9900173A3 (en) Herbicidal mixtures having a synergistic effect
HK1009401A1 (en) Synergistic combinations
SI1652433T2 (sl) Herbicidni sestavki
AU1372997A (en) Synergistic insecticidal mixtures
ZA948720B (en) Herbicidal substituted phenylaminosulphonylureas
IL119070A0 (en) Synergistic fungicidal compositions
ZA933374B (en) Synergistic herbicide combinations
ZA953065B (en) Insecticidal mixtures
IL116332A (en) Synergistic fungicidal mixtures
HUP9901686A3 (en) Fungicidal mixtures
ZA956265B (en) Herbicidal mixtures
HU9502218D0 (en) 4-phenoxycoumarins as herbicidal agents
ZA969798B (en) Herbicidal composition
ZA96400B (en) Herbicidal composition
ZA964324B (en) Herbicidal substituted 3-aryl-pyrazoles
IL124995A0 (en) Herbicidal compositions
GR3031150T3 (en) Fungicidal mixtures
GR3032558T3 (en) Fungicide mixtures
US5668087C1 (en) Herbicidal 1-alkenyltetrazolinones
IL122400A0 (en) Fungicidal mixtures
ZA947834B (en) Aryloxybenzene herbicidal agents
IL123896A0 (en) Fungicidal mixtures
IL126233A (en) Synergistic fungicidal mixtures
ZA984938B (en) Herbicidal mixtures